Buse JB, Vilsboll T, Thurman J, et al
Chao, when it comes to actual weight loss, injectable GLP-1 meds have averaged between 12% and 15% whole-body weight loss at higher doses over 68 weeks
They suggested that the discrepancy compared with previous reports was caused by the different specificity of the antibody used
Some patients may experience temporary sleep disruption during periods of active weight loss, though evidence for this specific to tirzepatide is limited
Discontinue tranexamic acid if a serious reaction occurs, provide appropriate medical management, and do not restart treatment
Dark Spot Reduction: The potent blend of ingredients works synergistically to reduce dark spots and other forms of skin discoloration, leaving behind a more uniform skin tone